We are live on ! Find out more
NRS

Neville Rodie & Shaw Portfolio holdings

AUM $1.55B
1-Year Est. Return 46.95%
This Fund
S&P 500
This Quarter Est. Return
-0.78%
1 Year Est. Return
+46.95%
3 Year Est. Return
+114.59%
5 Year Est. Return
+149.24%
10 Year Est. Return
+497.97%
AUM
$1.01B
AUM Growth
+$18.4M
Cap. Flow
+$33.5M
Cap. Flow %
3.3%
Top 10 Hldgs %
29.56%
Holding
285
New
19
Increased
86
Reduced
80
Closed
7

Top Buys

Rank Stock Value
1
EMR icon
Emerson Electric
EMR
+$4.54M
2
ABBV icon
AbbVie
ABBV
+$4.17M
3
MCD icon
McDonald's
MCD
+$3.64M
4
IBM icon
IBM
IBM
+$3.23M
5
DVN icon
Devon Energy
DVN
+$1.89M

Sector Composition

Rank Sector Weight
1 Energy 20.12%
2 Industrials 17.04%
3 Healthcare 14.87%
4 Technology 13.47%
5 Financials 9.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
1
ExxonMobil
XOM
$634B
$70.7M 6.97%
752,127
-5,255
-0.7% -$523K
SLB icon
2
SLB Ltd
SLB
$74.2B
$45.2M 4.46%
444,450
+10,509
+2% +$1.15M
JNJ icon
3
Johnson & Johnson
JNJ
$643B
$35.6M 3.51%
334,054
+13,355
+4% +$1.39M
AAPL icon
4
Apple
AAPL
$4.99T
$34.4M 3.39%
1,366,504
+19,360
+1% +$475K
MRK icon
5
Merck
MRK
$326B
$20.1M 1.98%
354,920
+12,768
+4% +$717K
IBM icon
6
IBM
IBM
$214B
$20M 1.97%
110,104
+17,721
+19% +$3.23M
BP icon
7
BP
BP
$107B
$18.6M 1.84%
518,669
+12,961
+3% +$513K
WFC icon
8
Wells Fargo
WFC
$263B
$18.5M 1.83%
357,535
-1,710
-0.5% -$88K
GOOG icon
9
Alphabet (Google) Class C
GOOG
$4.07T
$18.4M 1.81%
631,589
-5,876
-0.9% -$170K
GE icon
10
GE Aerospace
GE
$377B
$18.3M 1.8%
148,687
-836
-0.6% -$104K
TMO icon
11
Thermo Fisher Scientific
TMO
$214B
$17.4M 1.72%
143,200
+973
+0.7% +$118K
NSC icon
12
Norfolk Southern
NSC
$76.1B
$17M 1.68%
152,691
-850
-0.6% -$90.1K
QCOM icon
13
Qualcomm
QCOM
$172B
$16.4M 1.62%
219,743
+801
+0.4% +$61.3K
INTC icon
14
Intel
INTC
$435B
$15.1M 1.49%
434,164
-4,365
-1% -$148K
PCP
15
DELISTED
PRECISION CASTPARTS CORP
PCP
$14.9M 1.47%
62,889
-126
-0.2% -$30.6K
NEE icon
16
NextEra Energy
NEE
$186B
$14.2M 1.4%
606,764
-4,040
-0.7% -$97.6K
DD
17
DELISTED
Du Pont De Nemours E I
DD
$14M 1.38%
204,876
-105
-0.1% -$6.61K
GILD icon
18
Gilead Sciences
GILD
$167B
$13.9M 1.37%
130,574
-1,265
-1% -$124K
BKU icon
19
Bankunited
BKU
$3.39B
$13.1M 1.29%
430,350
+675
+0.2% +$21.5K
DIS icon
20
Walt Disney
DIS
$172B
$12.5M 1.23%
140,635
-1,010
-0.7% -$89.1K
CVX icon
21
Chevron
CVX
$374B
$12.1M 1.19%
101,448
+4,658
+5% +$594K
EPD icon
22
Enterprise Products Partners
EPD
$83.6B
$11.8M 1.16%
291,971
+21,343
+8% +$837K
SPY icon
23
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$11.3M 1.11%
57,279
+820
+1% +$162K
MDY icon
24
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.9B
$11.2M 1.1%
44,866
+671
+2% +$172K
PG icon
25
Procter & Gamble
PG
$347B
$10.8M 1.06%
128,987
+4,190
+3% +$343K

Similar funds

Neville Rodie & Shaw's Q3 2014 Portfolio in Review

As of Q3 2014, Neville Rodie & Shaw held 285 positions worth $1.01B, up 1.8% from $996M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Neville Rodie & Shaw deployed $33.5M of net new capital in Q3 2014, opening 19 new positions and adding to 86 existing holdings. Its largest new stake was Allergan plc: 5,703 shares worth $1.38M.

By sector, the portfolio is most concentrated in Energy at 20% of assets, down from 22% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Express Scripts Holding Company, an estimated $3.27M trimmed.

  • Neville Rodie & Shaw's largest Q3 2014 buy was Allergan plc: 5,703 shares worth $1.38M.
  • Neville Rodie & Shaw added most to Emerson Electric in Q3 2014, an estimated $4.54M increase.
  • Neville Rodie & Shaw's biggest Q3 2014 reduction was Express Scripts Holding Company, cutting an estimated $3.27M.
  • Neville Rodie & Shaw fully exited iShares Preferred and Income Securities ETF in Q3 2014, selling an estimated $973K.
  • Neville Rodie & Shaw's ten largest holdings make up 30% of its $1.01B portfolio in Q3 2014.
  • Neville Rodie & Shaw opened 19 new positions and closed 7 in Q3 2014.
  • Neville Rodie & Shaw's portfolio value rose 1.8% quarter-over-quarter to $1.01B.

Based on Neville Rodie & Shaw's 13F filing for Q3 2014, filed 10 Oct 2014.